Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SNDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 749.74M
March 31, 2026 779.29M
December 31, 2025 803.35M
September 30, 2025 790.06M
June 30, 2025 797.46M
March 31, 2025 764.43M
December 31, 2024 788.04M
September 30, 2024 894.34M
June 30, 2024 897.32M
March 31, 2024 902.56M
December 31, 2023 919.21M
September 30, 2023 962.62M
June 30, 2023 988.42M
March 31, 2023 996.51M
December 31, 2022 964.24M
Date Value
September 30, 2022 1.049B
June 30, 2022 1.174B
March 31, 2022 1.260B
December 31, 2021 1.052B
September 30, 2021 1.082B
June 30, 2021 1.075B
March 31, 2021 836.88M
December 31, 2020 208.20M
September 30, 2020 52.90M
June 30, 2020 77.91M
March 31, 2020 123.74M
December 31, 2019 166.94M
September 30, 2019 250.00M
June 30, 2019 14.25M
March 31, 2019 2.031M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
CannaPharmaRx, Inc. -30.83M
Bakhu Holdings Corp. --
SpeakEasy Cannabis Club Ltd. --
Tilray Brands, Inc. 1.614B
Clearmind Medicine, Inc. 11.49M

Shareholders Equity (Quarterly) Related Metrics